EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reprogramming the glycocalyx: Advances in glycoengineering for immunomodulation and regenerative medicine

Md Mohosin Rana, Peyman Malek Mohammadi Nouri, Seyed Hassan Hosseini, Bryce Roper, Stephen G Withers, Jayachandran N Kizhakkedathu

Biomaterials · 2026-03 · 326 · 123717

DOI: 10.1016/j.biomaterials.2025.123717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomaterials, 2026-03. Verfasst von Md Mohosin Rana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research and Life Sciences Institute, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada; Dep…. Hauptthemen laut MEDLINE: Glycocalyx, Regenerative Medicine, Immunomodulation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, University of British Columbia, Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores the evolving landscape of glycoengineering on the cell surface, a pivotal field in translational medicine with profound implications for immunomodulation and regenerative therapies. The cell membrane and glycocalyx, composed of proteins, lipids, and glycans, govern cellular interactions, immune recognition, and tissue regeneration. Given the dynamic nature and important biological roles of these structures, precise glycoengineering strategies are essential for modulating cell behavior without compromising function and safety. We delve into genetic and non-genetic approaches to manipulation of cell surface patterns, including targeted glycan and glycosaminoglycan modifications, metabolic glycoengineering, the use of synthetic glycopolymers, and bio-orthogonal glycan functionalization. Enzymatic strategies for glycan cleavage and addition further expand the toolkit for controlled cell surface remodeling. These advancements hold promise for cancer immunotherapy, organ transplantation, islet transplantation, and cardiovascular disease treatments. Despite the considerable potential of glycoengineering, a number of challenges, such as membrane instability and unintended cellular alterations remain, necessitating precise control over modifications. This review critically evaluates emerging strategies, discussing their limitations and future directions in biomedical and bioengineering applications. By integrating glycocalyx biology with advanced engineering techniques, we provide a roadmap for harnessing cell surface engineering to enhance therapeutic efficacy, immune modulation, biomaterial innovation, and regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxRegenerative MedicineImmunomodulationHumansAnimalsPolysaccharidesTissue Engineering

Stichwörter der Autor:innen

Biomaterial chemistry and engineeringCell surface modificationEnzymatic glycan editingGlycocalyxGlycoengineeringImmunomodulationMetabolic glycoengineeringRegenerative medicineSynthetic and natural glycopolymers

Substanzen

Polysaccharides

Autor:innen und Institutionen

  • Centre for Blood Research and Life Sciences Institute, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada; Department of Pathology and Laboratory Medicine, University of British Co…
  • Centre for Blood Research and Life Sciences Institute, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada; The School of Biomedical Engineering, University of British Columbia, Van…
  • Department of Chemistry, University of British Columbia, 2036 Main Mall, University of British Columbia, Vancouver, BC, V6T 1Z1, Canada.

Förderung

  • Canadian Institutes of Health Research
  • University of British Columbia
  • Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine
  • Centre for Blood Research, University of British Columbia
  • Canadian Glycomics Network
  • Michael Smith Health Research BC
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Rana, M. M., Mohammadi Nouri, P. M., Hosseini, S. H., Roper, B., Withers, S. G., & Kizhakkedathu, J. N. (2026). Reprogramming the glycocalyx: Advances in glycoengineering for immunomodulation and regenerative medicine. Biomaterials, 326, 123717. https://doi.org/10.1016/j.biomaterials.2025.123717

Vancouver

Rana MM, Mohammadi Nouri PM, Hosseini SH, Roper B, Withers SG, Kizhakkedathu JN. Reprogramming the glycocalyx: Advances in glycoengineering for immunomodulation and regenerative medicine. Biomaterials. 2026;326:123717. doi:10.1016/j.biomaterials.2025.123717

BibTeX
@article{Rana2026,
  author = {Rana, Md Mohosin and Mohammadi Nouri, Peyman Malek and Hosseini, Seyed Hassan and Roper, Bryce and Withers, Stephen G and Kizhakkedathu, Jayachandran N},
  title = {Reprogramming the glycocalyx: Advances in glycoengineering for immunomodulation and regenerative medicine},
  journal = {Biomaterials},
  year = {2026},
  volume = {326},
  pages = {123717},
  doi = {10.1016/j.biomaterials.2025.123717}
}
Kostenlos starten →